Literature DB >> 11939537

Iodine species and the endocrine system: thyroid hormone levels in adult Danio rerio and developing Xenopus laevis.

R Simon1, J E Tietge, B Michalke, S Degitz, K W Schramm.   

Abstract

Recently a new approach for the analysis of iodinated organic species in human serum has been developed using liquid chromatography-inductively coupled plasma-mass spectrometry (LC-ICP-MS). This method enables quantification of iodide, T4 and T3, as well as reverse T3 (rT3) and the synthetic precursors of TH, monoiodotyrosine (MIT), and diiodotyrosine (DIT) in a single injection. In this work, the LC-ICP-MS approach was used to analyze whole-body homogenates of adult male and female zebrafish (Danio rerio) and tadpoles of the African clawed frog (Xenopus laevis) at two different developmental stages (NF58 and 61) according to Nieuwkoop and Faber. The data demonstrate that the LC-ICP-MS method was successful at measuring I-, MIT, DIT, T4, T3, and rT3 in these two species. Furthermore, the method also detected five additional iodinated compounds which are currently unidentified.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11939537     DOI: 10.1007/s00216-001-1211-9

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  3 in total

1.  Analysis of thyroid hormones in serum by liquid chromatography-tandem mass spectrometry.

Authors:  Dongli Wang; Heather M Stapleton
Journal:  Anal Bioanal Chem       Date:  2010-05-01       Impact factor: 4.142

2.  Detection and quantification of 3,5,3'-triiodothyronine and 3,3',5'-triiodothyronine by electrospray ionization tandem mass spectrometry.

Authors:  Yuntao Zhang; Abigail H Conrad; Gary W Conrad
Journal:  J Am Soc Mass Spectrom       Date:  2005-09-22       Impact factor: 3.109

Review 3.  The state of the art of the zebrafish model for toxicology and toxicologic pathology research--advantages and current limitations.

Authors:  Jan M Spitsbergen; Michael L Kent
Journal:  Toxicol Pathol       Date:  2003 Jan-Feb       Impact factor: 1.902

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.